Lung tumors are divided into various types, such as small cell lung cancer, adenocarcinoma and squamous cell carcinoma. Many rare tumor types and sub-types also exist. This diversity hampers reliable rapid diagnostic methods ...
Jun 28, 2021
0
19
Drugs that are being trialed to treat leukemia could also be used to fight bowel cancer after a breakthrough by Hudson Institute of Medical Research scientists.
Jun 17, 2021
0
20
By studying the biomechanics of cancer in the breast and bladder, the Mechano-Control and Edit projects are developing new ways of cancer identification and treatment that could open up new avenues in cancer research
Jun 10, 2021
0
0
Breast cancer is the leading cause of cancer death in women around the world, responsible for 1,700 deaths every day. Although the vast majority of breast cancers are treatable, the most aggressive subtype—triple negative ...
Jun 7, 2021
0
14
A biomarker in the blood of patients with bowel cancer may provide valuable insight into the risk of cancer relapse after surgery and the effectiveness of chemotherapy.
Jun 3, 2021
0
10
Every tumor is different, every patient is different. So how do we know which treatment will work best for the patient and eradicate the cancer? In order to offer a personalized treatment that best suits the case being treated, ...
Jun 2, 2021
0
2
Researchers from the Francis Crick Institute, Royal Marsden, UCL and Cruces University Hospital have found that cells from different parts of kidney tumors behave differently, and surprisingly, cells within the center of ...
May 17, 2021
0
62
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.
May 14, 2021
0
22
A retrospective study conducted by scientists from the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital found that compiling a tumor molecular profile can result in better risk stratification ...
May 11, 2021
0
1
The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently ...
May 8, 2021
0
2
